Hannah Alison L.
Rigel Pharmaceuticals, Inc. · Director
Hannah Alison L. is listed in public filings as director. This Hannah Alison L. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL), and NeoGenomics, Inc. - Common Stock (NEO). Investors use Hannah Alison L.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --16.4k shares | Grant / ExerciseMay 15, 2026 | Disclosure amount unavailable5.8k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --12.3k shares | Grant / ExerciseJun 1, 2025 | Disclosure amount unavailable12.3k shares | -- | -- | |
| --23.1k shares | Grant / ExerciseJun 1, 2025 | Disclosure amount unavailable23.1k shares | -- | -- | |
| --131k shares | Grant / ExerciseJun 1, 2025 | Disclosure amount unavailable12.3k shares | -- | -- | |
| --131k shares | Grant / ExerciseJun 1, 2025 | Disclosure amount unavailable12.3k shares | -- | -- | |
| $117k16.1k shares | Grant / ExerciseJun 1, 2025 | $117.3K16.1k shares | $7.28 | -- | |
| --10.6k shares | Grant / ExerciseMay 23, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $57k3k shares | Grant / ExerciseMay 23, 2025 | $56.9K3k shares | $18.95 | -- | |
| --11.3k shares | Grant / ExerciseAug 10, 2024 | Disclosure amount unavailable11.3k shares | -- | -- |